Human stem cells expressing novel TSP-1 variant have anti-angiogenic effect on brain tumors.
van Eekelen
M
M
Molecular Neurotherapy and Imaging Laboratory, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02129, USA.
Sasportas
L S
LS
Kasmieh
R
R
Yip
S
S
Figueiredo
J-L
JL
Louis
D N
DN
Weissleder
R
R
Shah
K
K
D020533:Angiogenesis Inhibitors / Q000096:biosynthesis; D000818:Animals; D001932:Brain Neoplasms / Q000098:blood supply* / Q000378:metabolism / Q000473:pathology / Q000628:therapy*; D048708:Cell Growth Processes / Q000502:physiology; D045744:Cell Line, Tumor; D002478:Cells, Cultured; D004195:Disease Models, Animal; D042783:Endothelial Cells / Q000378:metabolism / Q000473:pathology; D005818:Genetic Engineering; D005910:Glioma / Q000098:blood supply* / Q000378:metabolism / Q000473:pathology / Q000628:therapy*; D006801:Humans; D051379:Mice; D009474:Neurons / Q000166:cytology / Q000637:transplantation; D033581:Stem Cell Transplantation / Q000379:methods*; D013234:Stem Cells / Q000378:metabolism*; D019700:Thrombospondin 1 / Q000378:metabolism*; D014161:Transduction, Genetic
D020533:Angiogenesis Inhibitors; D019700:Thrombospondin 1